This is supported by a number of in vitro and in vivo studies, which have demonstrated pro-tumourigenic effects of PARP1 in HCC including increased proliferation, growth, angiogenesis, invasion and metastatic gene mRNA upregulation [64,68]. Here, PARP1 is linked to hepatocellular carcinoma.